000 00912 a2200289 4500
005 20250516040752.0
264 0 _c20110817
008 201108s 0 0 cze d
022 _a0042-773X
040 _aNLM
_beng
_cNLM
100 1 _aHaluzĂ­k, M
245 0 0 _a[Treatment of type 2 diabetes mellitus with GLP-1 agonists].
_h[electronic resource]
260 _bVnitrni lekarstvi
_cApr 2011
300 _a411-5 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aExenatide
650 0 4 _aGlucagon-Like Peptide 1
_xagonists
650 0 4 _aHumans
650 0 4 _aIncretins
_xtherapeutic use
650 0 4 _aLiraglutide
650 0 4 _aPeptides
_xtherapeutic use
650 0 4 _aVenoms
_xtherapeutic use
700 1 _aUrbanová, M
700 1 _aTrachta, P
773 0 _tVnitrni lekarstvi
_gvol. 57
_gno. 4
_gp. 411-5
999 _c20872903
_d20872903